Investor Relations
The investor pages that follow are your resource for financial information about Achillion Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Jun 12, 2013
Achillion to Present at the Wells Fargo 2013 Healthcare Conference
May 30, 2013
Achillion Nominates ACH-3422 as Nucleotide for the Treatment of Chronic HCV
View all »Events & Presentations
Jun 18, 2013 at 8:50 AM
Fireside Chat - Wells Fargo 2013 Healthcare Conference
Jun 18, 2013 at 10:00 AM
HCV Panel - Wells Fargo 2013 Healthcare Conference
|